Why ValueChainPerformance?
Our experienced professionals will help bring your product to
commercialization for much less than half the cost.
Our business case is simple. If you are a
company with a product in late phase II or early phase III, you are about to
make a large investment in a commercial organization.
If you are a VC funded company or are looking to go the IPO route (or even
recently have), hiring a Head of Supply Chain, a Head of Quality, a Head of
Regulatory, pharmacovigilence personnel, and managed care personnel could cost
your organization upwards of $2.5 to $3million dollars annually.
This investment could significantly diminish your funds if your product
receives a non-approval or an approvable response from FDA. Under those two
scenarios, you now have a $2.5 to $3mm headcount that will be severely
underutilized for upwards of twelve months.
Why take that risk of proceeding without us? We can provide you
with everything your organization needs to begin its quest to commercialization
for much less than half the cost and is easily shed if your organization does
not meet its goal. Additionally, should you have success and achieve an
approvable status for your drug or medical device, we can assist in the
transition to a full time team for you.
Our consultants are very experienced in each of their
areas and work well as a team. We’ve done this before and with great success.
Is your business a foreign company that's not familiar with FDA and/or what is
required to enter the US market? we can accomplish this for you.
Everything from filing your drug or medical device with the FDA to setting up
your adverse events reporting database to getting your NDC code and getting
your product into the US wholesaler distribution channels. We can assist in
contracting with CMO’s, help achieve desired formulary status for you as well.
We’ve done this before and with great success. Let us do this for you and
reduce your financial risk.
|
